Leukocyte-Rich vs. Leukocyte-Poor Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis
In brief
An editorial weighing leukocyte-rich against leukocyte-poor platelet-rich plasma (PRP) for knee osteoarthritis, drawing mainly on a randomised trial and a related meta-analysis. Both forms appeared to give similar improvement, so the authors view either as reasonable, while pointing to limitations of the evidence and calling for larger, longer blinded trials.
Read the original paper (opens in a new tab)
Citation, as listed in the PRP guidelines
Leukocyte-Rich vs. Leukocyte-Poor Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis Authors: Ashim Gupta, Madhan Jeyaraman and Anish G. Potty Link: https://www.mdpi.com/2227-9059/11/1/141 Year of Publication: 2023
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the PRP guidelines
- Autologous Peripheral Blood-Derived Orthobiologics for the Management of Elbow Disorders: A Review of Current Clinical Evidence2025
- Intra-articular injections of hyaluronic acid versus plasma rich in growth factors (PRGF) for knee osteoarthritis: a meta-analysis of randomised controlled trials2025
- Comparison of Platelet-Rich Plasma and Corticosteroid Injections for Chronic Plantar Fasciitis: A Randomized Controlled Trial2024
- The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover, Randomized Controlled Trial with 12 Months Follow-up2024

